SCHEMBL25906451

SCHEMBL25906451

CCN(C(=O)[C@H](NC(=O)OC(C)(C)C)C(C)C)[C@@H](C)Cc1ccc2c(c1)OCO2

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.41
TAAR1 Q96RJ0 3/20 0.41
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
SLC6A3 Q01959 2/20 0.41
CYP2D6 P10635 1/20 0.41
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
ATM Q13315 1/20 0.40
HPGD P15428 3/20 0.39
KDM4E B2RXH2 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 2/20 0.38
CYP3A4 P08684 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25906665 0.90 SMN1; SMN2 (0.42) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL24883824 0.89 SMN1; SMN2 (0.42) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL25312868 0.88 SMN1; SMN2 (0.37) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL25312871 0.88 SMN1; SMN2 (0.37) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL25906543 0.85 ACE (0.46) SMN1; SMN2HPGDNPSR1ALDH1A1
SCHEMBL25906022 0.85 ACE (0.46) SMN1; SMN2HPGDNPSR1ALDH1A1
SCHEMBL25906020 0.83 TAAR1 (0.38) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL25311533 0.83 TAAR1 (0.47) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL25311529 0.83 TAAR1 (0.47) SMN1; SMN2TAAR1SLC6A2SLC6A4SLC6A3
SCHEMBL25314430 0.83 CA1 (0.40) SMN1; SMN2MAPTHPGDKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023137446-A1 PRODRUGS OF 3,4-METHYLENEDIOXY- N-ETHYL-AMPHETAMINE (MDEA) AND USES THEREOF TERRAN BIOSCIENCES INC. (US) 2023-07-20 WO disclosed